The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies

Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases

(2019) Jaume Alijotas-Reig et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Therapeutic apheresis during pregnancy: A single center experience

(2019) Anna Colpo et al.   TRANSFUSION AND APHERESIS SCIENCE

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study

(2019) Ariela Hoxha et al.   THROMBOSIS AND HAEMOSTASIS

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome

(2018) Cristina Belizna et al.   AUTOIMMUNITY REVIEWS

Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome

(2018) Patrizia Rovere-Querini et al.   MEDICINE

Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies

(2017) Guillermina Girardi   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile

(2017) J O Latino et al.   LUPUS

Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome

(2017) Alice Gustavsen et al.   MEDICINE

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies

(2017) Karen Schreiber et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies

(2016) S. Sciascia et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence

(2016) Patrick Cherin et al.   AUTOIMMUNITY REVIEWS

Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature

(2016) Sara Tenti et al.   AUTOIMMUNITY REVIEWS

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

(2016) Eleftheria Lefkou et al.   JOURNAL OF CLINICAL INVESTIGATION

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

(2016) Amelia Ruffatti et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

(2015) S. De Carolis et al.   AUTOIMMUNITY REVIEWS

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study

(2015) Arsène Mekinian et al.   AUTOIMMUNITY REVIEWS

Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss

(2015) Zachary S. Bowman et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block

(2015) Amelia Ruffatti et al.   TRANSFUSION AND APHERESIS SCIENCE

Statins and congenital malformations: cohort study

(2015) B. T. Bateman et al.   BMJ-British Medical Journal

Statins and congenital malformations: cohort study

(2015) B. T. Bateman et al.   BMJ-British Medical Journal

Clinical Improvement and Successful Pregnancy in a Preeclamptic Patient With Antiphospholipid Syndrome Treated With Pravastatin

(2014) Eleftheria Lefkou et al.   HYPERTENSION

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

(2014) T. Marchetti et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss

(2014) Nataliya Mar et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications

(2014) Yuko Matsuki et al.   Modern Rheumatology

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity

(2014) Elisa Salvan et al.   THROMBOSIS AND HAEMOSTASIS

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies

(2012) Michael D. Lockshin et al.   ARTHRITIS AND RHEUMATISM

Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study

(2012) R Fischer-Betz et al.   LUPUS

First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss

(2011) K. Bramham et al.   BLOOD

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study

(2011) A. Ruffatti et al.   RHEUMATOLOGY

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

(2009) J. H. Rand et al.   BLOOD

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome

(2009) K. Bramham et al.   LUPUS

Pregnancy Outcome in Women with Antiphospholipid Antibodies: Report on a Retrospective Study

(2009) Lothar Heilmann et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Case Reports of the Use of Immunoadsorption or Plasma Exchange in High-risk Pregnancies of Women With Antiphospholipid Syndrome

(2009) Maria Bortolati et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE